This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dobrzynski, H. Articles by Anderson, R. H. Search for Related Content PubMed PubMed Citation Articles by Dobrzynski, H. Articles by Anderson, R. H. Related Collections Structure Other myocardial biology Pacemaker Gene expression Ion channels/membrane transport

(Circulation. 2007;115:1921-1932.)
© 2007 American Heart Association, Inc.

Contemporary Reviews in Cardiovascular Medicine

New Insights Into Pacemaker Activity

Promoting Understanding of Sick Sinus Syndrome

Halina Dobrzynski, PhD; Mark R. Boyett, PhD; Robert H. Anderson, MD, FRCPath

From the Cardiovascular Research Group, School of Medicine, University of Manchester, Core Technology Facility, Manchester (H.D., M.R.B.); and Institute of Child Health, University College London, London (R.H.A.), UK.

Correspondence to Professor M.R. Boyett, Cardiovascular Research Group, School of Medicine, University of Manchester, Core Technology Facility, 46 Grafton St, Manchester M13 9NT, UK. E-mail mark.boyett{at}manchester.ac.uk

Key Words: arrhythmia • ion channels • pacemakers • sinoatrial node • sick sinus syndrome

	Introduction

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
Sick sinus syndrome is an abnormality involving the generation of the action potential by the sinus node and is characterized by an atrial rate inappropriate for physiological requirements. Manifestations include severe sinus bradycardia, sinus pauses or arrest, sinus node exit block, chronic atrial tachyarrhythmias, alternating periods of atrial bradyarrhythmias and tachyarrhythmias, and inappropriate responses of heart rate during exercise or stress.¹ Although its incidence increases in an exponential-like manner with age,¹ it can occur at all ages, including in the newborn.² The mean age of patients with the syndrome is 68 years, with both genders being affected in approximately equal proportion.² The syndrome occurs in 1 of every 600 cardiac patients older than 65 years and accounts for approximately half of implantations of pacemakers in the United States.² The syndrome is a collection of conditions, with a variety of causes intrinsic or extrinsic relative to the node.² Age-dependent degenerative fibrosis of the tissues of the node has been suggested to be a common cause,² although this is disputed.¹ Clinical aspects of the syndrome have been reviewed many times.^1–3 In this review, coinciding with the centenary of the discovery of the node, we offer new insights into intrinsic causes that come from an understanding of the mechanisms underlying pacemaking.

	Centenary of Discovery of Sinus Node

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
It is now exactly 100 years since Arthur Keith (Figure 1A) performed the work that introduced the world to the location of the sinus node.^4,5 Keith had been intrigued by the actions of the musculature of the heart and was anxious to establish any muscular mechanisms involved in closure of the great caval veins as the right atrium contracted to deliver its load to the ventricles.⁵ He was aware of the work of James Mackenzie, then a medical practitioner working in the north of England, and posed to Mackenzie the following question: "Are the caval venous openings closed when the right auricle contracts?" From Mackenzie, he received the reply, "You are the man I have been looking for; I have hearts which I observed in patients over a long series of years and now I want someone to examine them." As part of the histological examination of these hearts, Keith noted "a small condensed area of tissue, just where the cava sank into the auricle." At the time, Keith observed that "we noted this structure, but attached no functional meaning to it." Then, late in 1905, Mackenzie asked Keith to look into the state of the purported muscular connection between the atrial and ventricular musculatures, the so-called bundle of His. This structure had been described by His while working in Leipzig in 1893. Keith, however, had been unable to locate the bundle and had written a letter to the Lancet telling of his scepticism. Fortunately, by the time he received the proof from the Lancet, Mackenzie had sent him "a paper by Professor Aschoff, then of Marburg."⁵ Aschoff’s account was "based on a research carried out in his laboratory by Dr. S. Tawara, a Japanese." As Keith went on to describe, "With Tawara’s description and figures to guide me, I was able in heart after heart to verify the existence of Tawara’s system."⁵ It was no exaggeration for Keith to state, "With the discovery of the conducting system of Tawara, heart research entered a new epoch."⁵ Perhaps the first fruit of this new epoch was the equally significant discovery made by Keith himself.⁴ By the summer of 1906, Keith had enlisted the help of a young medical student, Martin Flack, the son of the local grocer and butcher. Together, Keith and Flack studied the hearts of smaller animals, such as the mole. Flack drew Keith’s attention to "a wonderful structure he had discovered in the right auricle of the mole."⁵ The arrangement of this structure immediately reminded Keith of the "small condensed area" seen in the human hearts made available by Mackenzie. Stimulated by this recollection, the pair "at once set to work on the sections we had already made, and found this structure in every one of them" (Figure 1B).⁵ Thus was discovered the sinus node! A few years after Keith’s discovery, in 1910, Wybau⁶ and Lewis⁷ demonstrated that the point of initial cardiac excitation corresponds to the location of the sinus node as revealed by Keith.⁴

View larger version (62K): [in this window] [in a new window]   Figure 1. A, Arthur Keith.5 B, Drawings made by Keith. Top, Dorsal view of atria of human heart to show site of section (*-*) through sinus node. Bottom, Section through node. Reproduced from Keith and Flack,4 with permission from Blackwell Publishing. Copyright 1907.

	Structure of Human Sinus Node

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
As can be confirmed by studies of the human heart (Figure 2A), the sinus node is indeed "a small condensed area of tissue" located "just where the cava [sinks] into the auricle."⁴ In the human heart, the cells making up the node occupy a subepicardial position adjacent to the terminal crest (crista terminalis), usually being arranged around a prominent nodal artery (Figure 2B), although the relationship to the artery varies from individual to individual.⁸ The nodal cells are set in a matrix of fibrous tissue, with a relatively discrete boundary seen between the margins of the node and the adjacent atrial tissues (Figure 2B).⁸ The earliest reconstructions of the node⁹ showed it to be a small discrete collection of tissues at the crest of the right atrial appendage, at the junction of the superior caval vein with the right atrium, but this is not typical. In a small proportion of cases, the node can extend across the crest of the right atrial appendage and occupy the interatrial groove.¹⁰ More typically, however, the node is lateral and inferior to the crest. When reconstructed from serial sections, it is found to take the form of a cigar, with a tail of varying dimensions extending down the terminal crest toward the orifice of the inferior caval vein (Figure 2A).⁸

View larger version (90K): [in this window] [in a new window]   Figure 2. A, Ventral view of right atrium of human heart during surgery to show location and extent of sinus node. B, Masson’s trichrome–stained section through human sinus node (approximately at level of dashed line in A).

	Structure of Sinus Node in Other Mammals

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
The location of the sinus node is different in the hearts of smaller mammals.^11–13 Nodal cells, instead of being located at the superior cavoatrial junction, occupy the full thickness of the intercaval area adjacent to the terminal crest, as shown by our recent reconstruction of the rabbit sinus node.¹¹ The reconstruction, shown in Figure 3, reveals the node to be extensive.¹¹ At its margins, zones of transitional cells, shown in blue in Figure 3, form the junction with the atrial muscle of the terminal crest.¹¹ In the rat, the node is positioned differently: The bulk of it lies in the superior caval vein, at the crest of the right atrial appendage, and tails of nodal tissue extend down both the terminal crest and the interatrial groove, as occurs in some humans (see above).¹² In the developing heart, the nodal primordium is extensive (Figure 4): In the mouse, as identified by marker genes such as the T-box transcription factor, Tbx3, a continuous tract of primary myocardium, the future nodal tissue, extends from the superior caval vein down the terminal crest (Figure 4, asterisk) to become continuous with the primary myocardium of the atrioventricular (AV) canal destined to form the AV node.^14,15 This is consistent with the distribution of nodal tissue in the adult rabbit (Figure 3). The continuous tract of primary myocardium in the developing heart is suggestive of an "internodal tract," such as that proposed by James¹⁶ to provide preferential conduction from the sinus node to the AV node. With the use of standard histological techniques in the postnatal heart, however, it is not possible to identify any insulated atrial tracts,¹⁷ and much of the primary myocardium loses the histological features of nodal tissue as the embryo matures.¹⁵ Furthermore, in the postnatal heart, preferential conduction from the sinus node to the AV node, as well as into the left atrium, can adequately be explained on the basis of the orderly longitudinal packing of atrial myocytes in prominent muscular bundles, such as the terminal crest and Bachmann’s bundle.¹⁶

View larger version (33K): [in this window] [in a new window]   Figure 3. Schematic diagram of dorsal view of rabbit heart showing location and extent of central (red) and peripheral (blue) sinus node tissue. Reproduced from Dobrzynski et al11 with permission from the American Heart Association. Copyright 2005.

View larger version (59K): [in this window] [in a new window]   Figure 4. Three-dimensional reconstruction of Tbx3-positive tissue (red) in relation to the lumen of the right (green) and left (yellow) ventricles of an E12.5 mouse heart. Ventral view is shown; note that the AV node, which is located dorsally, cannot be seen. Reproduced from Moorman et al15 with permission from the Heart Rhythm Society. Copyright 2005.

	Leading Pacemaking Site

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
Whereas in smaller mammals, the sinus node extends from the superior caval vein to the inferior caval vein (Figure 3),¹¹ in the human, the node, as identified by histology, is more restricted and extends only part of the way down the terminal crest (Figure 2A).⁸ Functional studies, nonetheless, have suggested that the node in the human may be as extensive as in smaller mammals. As shown in Figure 5, in the human, as in other mammals,^12,18,19 although the leading pacemaking site can be next to the superior caval vein, it can also be at any position between the superior and inferior caval veins.^20–22 In the dog, total ablation of pacemaker activity requires the destruction of a block of tissue 4 cm long and 1.5 cm wide, extending from the superior caval vein along the terminal crest to the inferior caval vein.²³ It is well known that the position of the leading pacemaking site in the node shifts depending on conditions, such as autonomic nerve stimulation.²⁴ It has been suggested that there is a hierarchy of pacemakers within the node, and the more superior the position, the faster is the heart rate. Stimulation of the sympathetic nervous system, for example, leads to a superior shift of the leading pacemaking site and an increase in heart rate.¹⁸ The potentially widespread distribution of nodal cells may also be important pathologically because ectopic sites along the terminal crest are known to be responsible for atrial tachycardia.²⁵ Ablation of the sites abolishes the tachycardias.²⁵

View larger version (56K): [in this window] [in a new window]   Figure 5. Position of leading pacemaker site (identified by arrows) in humans: in patients during open heart surgery (A) and in normal conscious subjects (B, C). Views of atria are shown. Spread of activation is shown by isochrones (in ms) or as color-coded map. Panel A reproduced from Boineau et al20 with permission from the American Heart Association. Copyright 1988. Panel B reproduced from Ramanathan et al21 with permission from the Nature Publishing Group, Macmillan Publishers Ltd. Copyright 2004. Panel C reproduced from Ramanathan et al22 with permission from the National Academy of Sciences, USA. Copyright 2006.

	Pacemaking Mechanisms

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
In Figure 6B and 6C, we show the sequence of atrial activation as measured in an experiment and as calculated with the anatomic model of the sinus node shown in Figure 3.^26,27 The action potential, initiated in the center of the node, propagates via the periphery of the node into the musculature of the terminal crest. In the center of the node, the action potential is slow and small compared with the action potential in the surrounding atrial muscle (Figure 6A). Most importantly, during diastole, whereas in the atrial muscle there is a stable resting potential, in the node the membrane is more depolarized, and there is a pacemaker potential, ie, a further time-dependent depolarization (Figure 6A). This pacemaker potential is responsible for pacemaking because, on reaching threshold, it initiates the action potential. Electric activity varies throughout the node: In the periphery, the action potential is faster and larger, and, curiously, the intrinsic pacemaker activity is faster than in the center (Figure 6D). Early attempts to understand the mechanisms underlying pacemaking were made in the 1970s,²⁸ and efforts to understand it continue today. It is a controversial topic,^29,30 perhaps because there is no one dominating mechanism but rather many contributory mechanisms. The depolarization during the pacemaker potential is the result of inward current, although it is facilitated by the decay of outward current (Figure 7).^31–35

View larger version (34K): [in this window] [in a new window]   Figure 6. Electric activity of rabbit sinus node. A, Action potentials recorded from center of node and neighboring atrial muscle. B, C, Activation sequence of node as measured in an experiment and as calculated with the use of anatomic model shown in Figure 3. B, C, Isochrones show spread of action potential (times in ms in B). D, Action potentials recorded from small balls of tissue dissected from center and periphery of node. Panel B reproduced from Boyett et al26 with permission from the American Physiological Society. Copyright 1999. Panel C reproduced from Boyett et al27 with permission from Elsevier, Inc. Copyright 2005.

View larger version (21K): [in this window] [in a new window]   Figure 7. Pacemaking mechanisms. A, Block of ICa,L by 2 µmol/L nifedipine abolishes action potential. Data from rabbit sinus node tissue. B, Block of If by 1 mmol/L Cs+ slows pacemaking. Data from isolated rabbit sinus node cell. C, Block of ICa,T by 40 µmol/L Ni2+ slows pacemaking. Data from isolated rabbit sinus node cell. D, Summary of ionic currents and ion channels involved in pacemaking. E, Block of highly TTX-sensitive INa (possibly carried by Nav1.1) and poorly TTX-sensitive INa (presumably carried by Nav1.5) by low and high doses of TTX slows pacemaking. Data from isolated mouse sinus node cell. F, "Block" of Ca2+ release from the SR by ryanodine slows pacemaking. Data from isolated guinea pig sinus node cell. Rigg and Terrar.35 Panel A reproduced from Kodama et al31 with permission from the American Physiological Society. Copyright 1997. Panel B courtesy of J.C. Denyer (doctoral thesis).32 Panel C reproduced from Hagiwara et al33 with permission from Blackwell Publishing. Copyright 1988. Panel E reproduced from Lei et al34 with permission from Blackwell Publishing. Copyright 2004. Panel F reproduced from Rigg and Terrar35 with permission from Blackwell Publishing. Copyright 2004.

Inward Currents
In the center of the node, the action potential upstroke is slow (Figure 6A) because the myocytes express little or no Na⁺ current, I_Na. It is the L-type Ca²⁺ current, I_Ca,L, that is principally responsible for the upstroke. I_Na, nonetheless, is important. In the rabbit, evidence suggests that, although I_Na is absent in the center of the node, it is present in the periphery.³⁶ Block of I_Na by tetrodotoxin (TTX) slows pacemaking in the periphery.³¹ I_Na may be more important in the mouse sinus node: Two components of I_Na have been recorded, a novel Na⁺ current that is blocked by nanomolar concentrations of TTX and the classic cardiac Na⁺ current that is blocked by micromolar concentrations of TTX.³⁴ Block of both components slows pacemaking by approximately one third (Figure 7E) and also increases the sinus node conduction time, ie, the time taken for the action potential to propagate out of the node.³⁴ It is possible, therefore, that I_Na plays 2 roles in the node: in pacemaking, especially in the mouse, and in action potential conduction (if the node is to drive the surrounding atrial muscle, it must be able to provide sufficient inward current to stimulate the atrial muscle, and this may be the function of I_Na, especially in the periphery).

Block of I_Ca,L abolishes the action potential in the center of the node (Figure 7A) because it is responsible for the action potential upstroke.³¹ The T-type Ca²⁺ current (I_Ca,T) is also involved in pacemaking; it is possibly involved in the second half of the pacemaker potential.³³ When I_Ca,T is blocked by Ni²⁺, spontaneous rate slows by 13% in rabbit nodal cells (Figure 7C).³³ The funny current, I_f, is also important. When I_f is blocked, spontaneous rate slows by 14% in the rabbit sinus node (Figure 7B).³⁷ Procoralan, or ivabradine, a blocker of I_f, is now being marketed as the first pure heart rate–lowering cardiac agent.³⁸

The Na⁺-Ca²⁺ exchanger is responsible for Ca²⁺ extrusion from cardiac myocytes (Figure 7D). The exchanger is electrogenic and generates an inward current (I_NaCa) during Ca²⁺ extrusion (Figure 7D). The total charge carried by inward I_NaCa is substantial: approximately half that carried by I_Ca,T and I_Ca,L, if the myocyte is to be in Ca²⁺ balance. If the extrusion of Ca²⁺ occurs in diastole, inward I_NaCa may make an important contribution to pacemaking. The source of Ca²⁺ that drives its extrusion via the exchanger is release from the sarcoplasmic reticulum (SR). All investigators agree that effective block of this release by ryanodine slows pacemaking (Figure 7F).^29,30,35,39 There is disagreement, nonetheless, over detail: whether Ca²⁺ release from the SR speeds pacemaking simply by activating the exchanger or by acting on other ionic currents as well^29,35; whether the Ca²⁺ release from the SR, critical for pacemaking, occurs spontaneously or in response to I_Ca,T^40,41; and whether complete block of the exchanger stops pacemaking or only slows it by 20%.^29,30 Li⁺ cannot substitute for Na⁺ in Na⁺-Ca²⁺ exchange, and abolition of inward I_NaCa by substitution of extracellular Na⁺ by Li⁺ also results in a slowing of pacemaking.²⁹ Recently, Vinogradova et al⁴² argued that spontaneous release of Ca²⁺ from the SR, which drives pacemaking, occurs because the basal level of cAMP in the node is high. A heterozygous ankyrin-B knockout mouse shows both bradycardia and sinus dysrhythmia.⁴³ Ankyrin-B is a membrane adaptor protein involved in the cellular organization of the Na⁺ pump, the Na⁺-Ca²⁺ exchanger, and the IP₃ receptor. Myocytes from the heterozygous ankyrin-B knockout mouse show disturbed intracellular Ca²⁺ handling.⁴³ Could the bradycardia be the result of a change in I_NaCa?

Outward Currents
The background inward rectifier K⁺ current, I_K,1, is largely responsible for the stable resting potential in the working myocardium. Despite the presence of I_K,1, Purkinje fibers show I_f-dependent pacemaking, but the pacemaking is slow and not robust. Perhaps the most important factor responsible for the rapid and robust pacemaking of the node is the absence of I_K,1 within the node.⁴⁴ During the action potential in the node, there is an activation of the rapid and slow delayed rectifier K⁺ currents, I_K,r and I_K,s; this helps to bring about repolarization and determines the maximum diastolic potential. During diastole, I_K,r and I_K,s decay slowly, facilitating the pacemaker potential by "uncovering" inward current. This is known as the K⁺ decay hypothesis.⁴⁴ In Drosophila, a background K⁺ channel (2-pore K⁺ channel, ORK1) has been shown to affect cardiac pacemaking.⁴⁵

	Ion Channels

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
Ion channel expression in the sinus node has been studied at the mRNA and protein levels and, as expected, is radically different from that in the working myocardium.

Na⁺ Channels
The cardiac Na⁺ channel, Na_v1.5, encoded by the SCN5A gene, is responsible for the classic cardiac Na⁺ current that is blocked by micromolar concentrations of TTX. Consistent with the electrophysiology, in both the human (Figure 8A) and other mammals (Figure 9), Na_v1.5 is present in the atrial muscle and the periphery of the node but absent from the center.^34,46 Despite this, in the mouse, knockout of Na_v1.5 results in bradycardia, an increase in sinus node conduction time, and frequent sinus node conduction block.⁴⁷ Knockout of the Na⁺ channel ß₂ subunit also results in bradycardia.⁴⁸ Recently, various brain-type Na⁺ channels, including Na_v1.1, have also been shown to be expressed in cardiac myocytes.⁴⁹ They are blocked by nanomolar concentrations of TTX. Na_v1.1, in contrast to Na_v1.5, is present in the node as well as the atrial muscle. It is likely to be responsible for the component of Na⁺ current in mouse sinus node blocked by nanomolar concentrations of TTX.^34,46

View larger version (39K): [in this window] [in a new window]   Figure 8. Expression of ion channel proteins in human sinus node as revealed by immunohistochemistry. A to C, Labeling of Nav1.5, HCN4, and Kir2.1 in atrial muscle of terminal crest and node.

View larger version (33K): [in this window] [in a new window]   Figure 9. Expression of ion channel proteins (top, Nav1.5; bottom, HCN4) in rat sinus node as revealed by immunohistochemistry.

Ca²⁺ Channels
In the working myocardium, Ca_v1.2 (_1C) is the principal isoform responsible for I_Ca,L, but in the node, Ca_v1.3 (_1D) may be the principal isoform.⁵⁰ Ca_v1.3 has a more negative threshold potential⁵¹ and may be more appropriate for pacemaking. In the mouse, knockout of Ca_v1.3 causes bradycardia and sinus dysrhythmia, and this is linked to abolition of the major component of I_Ca,L activating at negative voltages.^51,52 Ca_v3.1 and Ca_v3.2 channels are responsible for I_Ca,T in heart. In the mouse, Ca_v3.1 mRNA is 30 times more abundant in the node than in the atrial muscle. Ca_v3.2 mRNA, although less abundant, is also more abundant in the node than in the atrial muscle.⁵³ In the mouse, knockout of Ca_v3.1 abolishes I_Ca,T in nodal cells, causes a bradycardia in vivo, slows the intrinsic heart rate in vivo, prolongs the sinus node recovery time, and slows pacemaking in vitro.⁵⁴

HCN Channels
HCN channels (HCN1, HCN2, and HCN4) are responsible for I_f in heart. HCNs are highly expressed in the node in both the human (Figure 8B) and other mammals (Figure 9).¹² The dominant HCN transcript is HCN4.^55,56 In the rabbit sinus node, HCN4 mRNA accounts for approximately four fifths of total HCN mRNA, HCN1 mRNA accounts for approximately one fifth, and HCN2 mRNA accounts for only 1%.⁵⁵ In the mouse, knockout of the HCN2 gene results in a reduction of 30% in I_f in nodal cells.⁵⁷ In vivo there is no significant bradycardia, but there is sinus dysrhythmia.⁵⁷ HCN4 knockout mice die before birth, but the embryos exhibit a severe bradycardia and an 85% decrease in cardiac I_f.⁵⁸

K⁺ Channels
In the rabbit, at least, there is a slowly recovering transient outward current, I_to, in the atrial muscle and a rapidly recovering one in the node.⁵⁹ Consistent with this, there is a switch from K_v1.4 in the atrial muscle to K_v4.2 in the node.⁵⁰ K_v1.5 is responsible for ultrarapid delayed rectifier K⁺ current, an important repolarizing current in the atrium. In the guinea pig, it is expressed in the node as well as the atrium.⁶⁰ Consistent with the electrophysiology, both ERG (responsible for I_K,r) and K_vLQT1 (responsible for I_K,s) mRNA are expressed in the rabbit sinus node, and expression is higher than in the atrial muscle.⁵⁰ K_ir2 channels, responsible for I_K,1, are not expected to be expressed in the node. Possible evidence of such a restriction of expression comes from a study of a transgenic mouse overexpressing K_ir2.1 (Figure 10A).⁶¹ Figure 8C shows that, in the human, K_ir2.1 (this time the native channel) is indeed not expressed in the node, although it is expressed in atrial muscle. Evidence suggests that, whereas the abundance of K_ir3.1 and K_ir3.4, responsible for acetylcholine-activated K⁺ current, I_K,ACh, is equal in the node and atrial muscle, the abundance of Kir6.2 and SUR2A, responsible for ATP-sensitive K⁺ current, I_K,ATP, may be reduced in the node compared with in the atrial muscle.^50,62

View larger version (48K): [in this window] [in a new window]   Figure 10. Expression of -myosin heavy chain promoter–driven, green fluorescent protein–tagged Kir2.1 transgene in sinus node and atrial muscle of mouse. A, B, Low-magnification images of Kir2.1 (A; green) and Cx43 (B; red) in node and surrounding atrial muscle. C, D, High-magnification images of Kir2.1 in periphery of node and terminal crest (C) and center of node (D). Reproduced from Dobrzynski et al61 with permission from Elsevier, Inc. Copyright 2006.

	Gap Junctions

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
Whereas electric coupling in the working myocardium is strong, facilitating rapid conduction of the action potential, electric coupling within the sinus node is poor, and consequently conduction is slow.^24,63 This is important functionally because it protects the pacemaking tissue from the hyperpolarizing influence of the surrounding atrial muscle.⁶⁴ If electric coupling was uniformly poor throughout the node, the node would be unable to drive atrial muscle. It has been postulated, therefore, that there should be strong electric coupling at the periphery of the node.⁶⁴ Gap junction channels, composed of connexins, are responsible for electric coupling between myocytes. In the atrial muscle, the strong electric coupling is the result of the abundant expression of Cx43 and perhaps Cx40, which form medium and large conductance channels.⁶³ In the center of the node, electric coupling is weak because Cx43 and Cx40 are either absent or poorly expressed (eg, Figure 10B).^61,63 Cx45, which forms small conductance channels, is expressed in the center of the node instead.⁶³ Recently, Cx30.2 has been found to be expressed abundantly in the mouse conduction system, whereas it is weakly expressed in the working myocardium.⁶⁵ Cx30.2 forms small conductance homomeric channels and small conductance heteromeric channels with Cx43 and Cx40.⁶⁵ There is evidence that electric coupling is stronger in the periphery of the node: In the rabbit, 3 connexins (Cx40, Cx45, and Cx43) are expressed in the periphery.⁶³ In various species, including humans, interdigitations of atrial and nodal cells in the periphery of the node have been reported.⁶³ It has been suggested on theoretical grounds that these interdigitations permit the node to drive the surrounding atrial muscle and at the same time to be protected from the hyperpolarizing influence of the atrial muscle.⁶⁶ In Cx40 knockout mice, there is evidence of bradycardia, sinus node exit and entry block, and a prolongation of the sinus node conduction time.⁶⁷

	New Insights

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
Familial Sick Sinus Syndrome
As explained above and as summarized in the Table, the knockout of various ion channel and gap junction subunits in transgenic mice has been shown to result in a sick sinus syndrome phenotype, with bradycardia, sinus dysrhythmia, and sinus node exit block.^* These studies raise the possibility that sick sinus syndrome as seen clinically is related to problems with ion channels and gap junctions. In the case of familial sick sinus syndrome, at least, the disease has been shown to be the result of mutations in ion channels (Table). Various families have been identified with sick sinus syndrome linked to mutations in Na_v1.5 (Figure 11A).^69,71,72 This is paradoxical because Na_v1.5 is absent from the center of the node (Figure 8A). The dysfunction must be the result of impaired function of Na_v1.5 at the periphery of the node (Figure 9). In addition, in patients, sinus bradycardia/sick sinus syndrome has also been linked to mutations in HCN4^73–76 (Figure 11B) and ankyrin-B.⁴³

View this table: [in this window] [in a new window]   Ion Channels (Carrying Mutations) Known to Result in Familial Sick Sinus Syndrome in Humans and Ion Channels (When Knocked Out) Known to Result in Sinus Node Dysfunction in Mice

View larger version (23K): [in this window] [in a new window]   Figure 11. A, B, Mutations in Nav1.5 and HCN4 known to be responsible for sinus bradycardia/sick sinus syndrome in patients. C, Stimulus-evoked action potential in control ventricular myocyte (top) and spontaneous action potentials in Kir2.1AAA-transduced myocyte with suppressed IK,1 (bottom). Reproduced from Miake et al76 with permission from the Nature Publishing Group, Macmillan Publishers Ltd. Copyright 2002.

Sick Sinus Syndrome and Aging
Because the syndrome is age dependent,¹ it is possible that the disease can be no more than an exaggeration of the normal aging process. The function of the node is known to decline during aging in both humans and other mammals.^1,77 This is manifested as a decrease in the intrinsic heart rate and an increase in the sinus node conduction time.^1,77 The age-dependent changes in the node could be the result of changes in ion channels and gap junctions. It has been argued that the presence of Na_v1.5 (Figure 9) and I_Na in the periphery of the node is important for the node to be able to drive the surrounding atrial muscle. An age-dependent slowing of the action potential upstroke in the periphery of the rabbit sinus node⁷⁷ is evidence of a loss of I_Na from the periphery during aging, and this could help to explain the deterioration in nodal function, ie, the increase in sinus node conduction time and sinus node exit block.⁷⁸ There is an increase in action potential duration in the rabbit and cat sinus node during aging⁷⁷; is this the result of an age-dependent decrease in K_v1.5 observed in the rat sinus node?⁷⁹ In the guinea pig, there is a decrease in the expression of Cx43 in the region of the node during aging, with an 14-fold increase in the area of nodal tissue without Cx43.⁸⁰ Like the suggested loss of I_Na from the node during aging, this could help to explain the increase in the sinus node conduction time and occurrence of sinus node exit block with aging.⁸⁰

Remodeling of the Sinus Node in Heart Failure and Atrial Fibrillation
In the United States, up to 5 million patients experience congestive heart failure, and sudden cardiac death is a significant problem in this population.⁸¹ Bradyarrhythmias account for almost half of the sudden deaths in the hospital.⁸¹ It is now known that heart failure results in significant remodeling of the node.^81,82 In the human, dog, and rabbit, there is a decrease in the intrinsic heart rate during heart failure.^81,83–85 Sanders et al⁸¹ demonstrated that, in patients with congestive heart failure as well as a decrease in the intrinsic heart rate, there is an increase in the corrected sinus node recovery time, a caudal shift of the leading pacemaker site, fractionated electrograms or double potentials along the terminal crest, a decrease in the amplitude of the electrograms along the terminal crest, and abnormal propagation of the action potential from the node. Changes in sensitivity of the node to acetylcholine and vagal stimulation have been observed in heart failure in the rabbit and dog.^82,84 With heart failure, in the rabbit, block of I_f by zatebradine causes a smaller decrease in the heart rate,⁸⁶ and the decrease in sinus node pacemaking has been attributed to a decrease in I_f.⁸⁷ With heart failure, in the dog, a decrease in HCN2 and HCN4 mRNA and protein by 80% is observed in the node.⁸⁸

Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and in the atria is well known to result in an electrophysiological remodeling.⁸⁹ Clinical studies have shown that sick sinus syndrome is frequently associated with AF and atrial flutter, the "bradycardia-tachycardia syndrome."^90,91 Clinical studies have shown that chronic AF is associated with significant damage to the node and the nodal artery.⁹² In the dog, rapid atrial pacing at 400 bpm for 16 days, as well as chronic AF, results in nodal dysfunction: prolongation of the sinus node recovery time and decreases in the intrinsic and maximal heart rates.^93,94 Comparable data have been reported in the human.^95–99 For example, symptomatic prolonged sinus pauses on termination of AF are an indication for pacemaker implantation.⁹⁷ In these patients, however, after AF ablation, there is a significant improvement in nodal function (increase in heart rate, maximal heart rate and heart rate range, and decrease in corrected sinus node recovery time).⁹⁷ This corresponds to a recovery of the node from remodeling during AF.⁹⁷ In patients, termination of chronic atrial flutter by ablation also leads to recovery of nodal function.⁹⁵ In the human, rapid atrial pacing for only 10 to 15 minutes alters nodal function.¹⁰⁰

	Future Directions

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 
Sick sinus syndrome is a collection of conditions with multiple causes. Although degenerative fibrosis may be an important cause, it is clear that ion channels underlie the familial disease, as well as the variants related to heart failure and AF. They may also be important in the aging-related syndrome. If this is the case, manipulation of the expression of the genes regulating the ion channels in the node could be a powerful therapeutic tool. Recently, there has been much interest in generating a "biopacemaker" by manipulation of ion channel genes in the working myocardium.^76,101 To date, attention has focused on either knocking out K_ir2.1, and thus I_K,1, because K_ir2.1 is not expressed in the node (eg, Figure 8C), or expressing an HCN channel because HCNs are abundantly expressed in the node (eg, Figure 8B).^76,101 An example of the conversion of a ventricular cell into a biopacemaker (by knocking out K_ir2.1) is shown in Figure 11C. There are, however, many differences in the expression of ion channels between the sinus node and working myocardium, as we have explained above,⁵⁰ and perhaps >1 ion channel has to be manipulated to make an effective and robust new pacemaker. An alternative and potentially more attractive possibility could be the transfer of an appropriate gene into the node itself to correct sick sinus syndrome.

	Acknowledgments

 
Disclosures

Dr Dobrzynski has received a research grant from Medtronic. The other authors report no conflicts of interest.

	Footnotes

 
*References ^{43, 47, 48, 51, 52, 54, 57, 58, 67–75}.

	References

Top Introduction Centenary of Discovery of... Structure of Human Sinus... Structure of Sinus Node... Leading Pacemaking Site Pacemaking Mechanisms Ion Channels Gap Junctions New Insights Future Directions References

 

1. Benditt DG, Sakaguchi S, Goldstein MA, Lurie KG, Gornick CC, Adler SW. Sinus node dysfunction: pathophysiology, clinical features, evaluation, and treatment. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, Pa: WB Saunders Company; 1995: 1215–1247.
   
2. Adan V, Crown LA. Diagnosis and treatment of sick sinus syndrome. Am Fam Physician. 2003; 67: 1725–1732.[Medline] [Order article via Infotrieve]
   
3. Mangrum JM, DiMarco JP. The evaluation and management of bradycardia. N Engl J Med. 2000; 342: 703–709.[Free Full Text]
   
4. Keith A, Flack MW. The form and nature of the muscular connections between the primary divisions of the vertebrate heart. J Anat Physiol. 1907; 41: 172–189.[Medline] [Order article via Infotrieve]
   
5. Keith A. An Autobiography: Sir Arthur Keith. London, UK: Watts & Co; 1950.
   
6. Wybauw R. Sur le point d’origine de la systole cardiaque dans l’oreillette droite. Arch internat d Physiol. 1910; 10: 78–90.
   
7. Lewis T, Oppenheimer BS, Oppenheimer A. The site of origin of the mammalian heart beat: the pacemaker in the dog. Heart. 1910; 2: 147–169.
   
8. Sanchez-Quintana D, Cabrera JA, Farre J, Climent V, Anderson RH, Ho SY. Sinus node revisited in the era of electroanatomical mapping and catheter ablation. Heart. 2005; 91: 189–194.[Abstract/Free Full Text]
   
9. James TN. Anatomy of the human sinus node. Anat Rec. 1961; 141: 109–139.[CrossRef][Medline] [Order article via Infotrieve]
   
10. Anderson KR, Ho SY, Anderson RH. Location and vascular supply of sinus node in human heart. Br Heart J. 1979; 41: 28–32.[Abstract/Free Full Text]
    
11. Dobrzynski H, Li J, Tellez J, Greener ID, Nikolski VP, Wright SE, Parson SH, Jones SA, Lancaster MK, Yamamoto M, Honjo H, Takagishi Y, Kodama I, Efimov IR, Billeter R, Boyett MR. Computer three-dimensional reconstruction of the sinoatrial node. Circulation. 2005; 111: 846–854.[Abstract/Free Full Text]
    
12. Yamamoto M, Dobrzynski H, Tellez J, Niwa R, Billeter R, Honjo H, Kodama I, Boyett MR. Extended atrial conduction system characterized by the expression of the HCN4 channel and connexin45. Cardiovasc Res. 2006; 72: 271–281.[Abstract/Free Full Text]
    
13. Anderson RH. The disposition, morphology and innervation of cardiac specialized tissue in the guinea-pig. J Anat. 1972; 111: 453–468.[Medline] [Order article via Infotrieve]
    
14. Rentschler S, Vaidya DM, Tamaddon H, Degenhardt K, Sassoon D, Morley GE, Jalife J, Fishman GI. Visualization and functional characterization of the developing murine cardiac conduction system. Development. 2001; 128: 1785–1792.[Abstract]
    
15. Moorman AF, Christoffels VM, Anderson RH. Anatomic substrates for cardiac conduction. Heart Rhythm. 2005; 2: 875–886.[CrossRef][Medline] [Order article via Infotrieve]
    
16. James TN. The connecting pathways between the sinus node and A-V node and between the right and the left atrium in the human heart. Am Heart J. 1963; 66: 498–508.[CrossRef][Medline] [Order article via Infotrieve]
    
17. Janse MJ, Anderson RH. Specialized internodal atrial pathways: fact or fiction? Eur J Cardiol. 1974; 2: 117–136.
    
18. Schuessler RB, Boineau JP, Bromberg BI. Origin of the sinus impulse. J Cardiovasc Electrophysiol. 1996; 7: 263–274.[Medline] [Order article via Infotrieve]
    
19. Betts TR, Ho SY, Sanchez-Quintana D, Roberts PR, Anderson RH, Morgan JM. Three-dimensional mapping of right atrial activation during sinus rhythm and its relationship to endocardial architecture. J Cardiovasc Electrophysiol. 2002; 13: 1152–1159.[CrossRef][Medline] [Order article via Infotrieve]
    
20. Boineau JP, Canavan TE, Schuessler RB, Cain ME, Corr PB, Cox JL. Demonstration of a widely distributed atrial pacemaker complex in the human heart. Circulation. 1988; 77: 1221–1237.[Abstract/Free Full Text]
    
21. Ramanathan C, Ghanem RN, Jia P, Ryu K, Rudy Y. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat Med. 2004; 10: 422–428.[CrossRef][Medline] [Order article via Infotrieve]
    
22. Ramanathan C, Jia P, Ghanem R, Ryu K, Rudy Y. Activation and repolarization of the normal human heart under complete physiological conditions. Proc Natl Acad Sci U S A. 2006; 103: 6309–6314.[Abstract/Free Full Text]
    
23. Kalman JM, Lee RJ, Fisher WG, Chin MC, Ursell P, Stillson CA, Lesh MD, Scheinman MM. Radiofrequency catheter modification of sinus pacemaker function guided by intracardiac echocardiography. Circulation. 1995; 92: 3070–3081.[Abstract/Free Full Text]
    
24. Boyett MR, Honjo H, Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res. 2000; 47: 658–687.[Abstract/Free Full Text]
    
25. Kistler P, Haqqani H, Fynn S, Stevenson I, Vohra J, Sparks P, Kalman JM. RF ablation of focal atrial tachycardia: anatomic distribution and long term follow-up in a large consecutive single center series. Heart Rhythm. 2004; 1: S236.
    
26. Boyett MR, Honjo H, Yamamoto M, Nikmaram MR, Niwa R, Kodama I. Downward gradient in action potential duration along the conduction path in and around the sinoatrial node. Am J Physiol. 1999; 276: H686–H698.[Medline] [Order article via Infotrieve]
    
27. Boyett MR, Li J, Inada S, Dobrzynski H, Schneider JE, Holden AV, Zhang H. Imaging the heart: computer three-dimensional anatomical models of the heart. J Electrocardiol. 2005; 38: 113–120.[Medline] [Order article via Infotrieve]
    
28. Brown HF, Clark A, Noble SJ. Pacemaker current in frog atrium. Nat New Biol. 1972; 235: 30–31.[CrossRef][Medline] [Order article via Infotrieve]
    
29. Bogdanov KY, Vinogradova TM, Lakatta EG. Sinoatrial nodal cell ryanodine receptor and Na⁺-Ca²⁺ exchanger: molecular partners in pacemaker regulation. Circ Res. 2001; 88: 1254–1258.[Abstract/Free Full Text]
    
30. Honjo H, Inada S, Lancaster MK, Yamamoto M, Niwa R, Jones SA, Shibata N, Mitsui K, Horiuchi T, Kamiya K, Kodama I, Boyett MR. Sarcoplasmic reticulum Ca²⁺ release is not a dominating factor in sinoatrial node pacemaker activity. Circ Res. 2003; 92: e41–e44.[Abstract/Free Full Text]
    
31. Kodama I, Nikmaram MR, Boyett MR, Suzuki R, Honjo H, Owen JM. Regional differences in the role of the Ca²⁺ and Na⁺ currents in pacemaker activity in the sinoatrial node. Am J Physiol. 1997; 272: H2793–H2806.[Medline] [Order article via Infotrieve]
    
32. Denyer JC. Isolation and Electrophysiological Characteristics of Rabbit Sino-atrial Node Cells. Oxford, UK: University of Oxford; 1989.
    
33. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol. 1988; 395: 233–253.[Abstract/Free Full Text]
    
34. Lei M, Jones SA, Liu J, Lancaster MK, Fung SS, Dobrzynski H, Camelliti P, Maier SK, Noble D, Boyett MR. Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking. J Physiol. 2004; 559: 835–848.[Abstract/Free Full Text]
    
35. Rigg L, Terrar DA. Possible role of calcium release from the sarcoplasmic reticulum in pacemaking in guinea-pig sino-atrial node. Exp Physiol. 1996; 81: 877–880.[Abstract]
    
36. Honjo H, Boyett MR, Kodama I, Toyama J. Correlation between electrical activity and the size of rabbit sinoatrial node cells. J Physiol. 1996; 496: 795–808.[Medline] [Order article via Infotrieve]
    
37. Nikmaram MR, Boyett MR, Kodama I, Suzuki R, Honjo H. Variation in the effects of Cs⁺, UL-FS 49 and ZD7288 within the sinoatrial node. Am J Physiol. 1997; 272: H2782—H2792.[Medline] [Order article via Infotrieve]
    
38. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective I_f current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs. 2004; 64: 1757–1765.[CrossRef][Medline] [Order article via Infotrieve]
    
39. Ju Y-K, Allen DG. Intracellular calcium and Na²⁺-Ca²⁺ exchange current in isolated toad pacemaker cells. J Physiol. 1998; 508: 153–166.[Abstract/Free Full Text]
    
40. Vinogradova TM, Zhou YY, Maltsev V, Lyashkov A, Stern M, Lakatta EG. Rhythmic ryanodine receptor Ca²⁺ releases during diastolic depolarization of sinoatrial pacemaker cells do not require membrane depolarization. Circ Res. 2004; 94: 802–809.[Abstract/Free Full Text]
    
41. Huser J, Blatter LA, Lipsius SL. Intracellular Ca²⁺ release contributes to automaticity in cat atrial pacemaker cells. J Physiol. 2000; 524: 415–422.[Abstract/Free Full Text]
    
42. Vinogradova TM, Lyashkov AE, Zhu W, Ruknudin AM, Sirenko S, Yang D, Deo S, Barlow M, Johnson S, Caffrey JL, Zhou YY, Xiao RP, Cheng H, Stern MD, Maltsev VA, Lakatta EG. High basal protein kinase A-dependent phosphorylation drives rhythmic internal Ca²⁺ store oscillations and spontaneous beating of cardiac pacemaker cells. Circ Res. 2006; 98: 505–514.